Peer Comparison
| Company | Market Price | MCAP(Cr) | P/B | P/E | EPS | ROE |
|---|---|---|---|---|---|---|
| NATCOPHARM | 793.95(0.7%) | 14,058 | 2.7 | 12.5 | 18.1 | 15.7 |
| APLLTD | 750.1(0.5%) | 14,764 | 3.3 | 27.8 | 7.2 | 7.1 |
| ERIS | 916.5(-1.1%) | 12,574 | 5.2 | 32.6 | 17.3 | 18.3 |
| ASTRAZEN | 4800(0.8%) | 11,909 | 18.2 | 77.9 | 24.5 | 18.1 |
| SUVENPHAR | 673(2.1%) | 17,160 | 8.9 | 39.7 | 33.4 | 25.2 |
| CAPLIPOINT | 1302.3(-0.4%) | 9,820 | 4.7 | 23.5 | 26.8 | 23.7 |
| GRANULES | 392.3(2.6%) | 9,518 | 3.2 | 24.2 | 17.4 | 17.5 |
| MEDPLUS | 783.8(-1.4%) | 9,468 | 6.2 | 162.3 | 9.6 | 3.5 |
| PFIZER | 4042.65(-1.5%) | 18,749 | 5.3 | 136.7 | 27.6 | 20.6 |
| SANOFI | 8218.75(0.5%) | 18,921 | 22.7 | 121.3 | 59.8 | 40.8 |
| PGHL | 5152.05(0.5%) | 8,519 | 10.5 | 36.8 | 46.1 | 33.9 |
| GLS | 640(1.0%) | 7,798 | 3.3 | 15.4 | 30.0 | 22.3 |
| LAURUSLABS | 378.35(-0.7%) | 20,401 | 5.1 | 55.5 | 23.0 | 21.6 |
| MARKSANS | 170(1.9%) | 7,504 | 4.0 | 25.2 | 22.9 | 18.6 |
| PEL | 939.2(1.4%) | 20,853 | 0.7 | 5.3 | 11.7 | 30.0 |
